Teleflex Could See 'Muted' Business Through Business Separation in Mid-2026, RBC Says

MT Newswires Live
2025/03/01

Teleflex (TFX) could see "muted" business through the completion of its planned separation in mid-2026, RBC Capital Martkets said in a Friday note.

On Thursday, Teleflex said its board approved a plan to separate the Urology, Acute Care, and OEM segments into a publicly traded company.

The company announced the separation the same day it released its Q4 results and issued guidance for 2025. Teleflex reported Q4 adjusted earnings from continuing operations of $3.89 per diluted share and $795.4 million in revenue, and guided 2025 adjusted EPS at $13.95 to $14.35.

According RBC, the Q4 top-line miss, disappointing 2025 revenue growth outlook, and business separation plan raise questions over Teleflex's current business state. The company also faces potential headwind from new US tariffs, the investment firm added.

"We view TFX's new strategic direction favorably, but believe it'll be sometime before it begins to drive shareholder value," RBC said.

RBC downgraded Teleflex to sector perform from outperform, with a lower price target of $155 from $220 previously.

Price: 134.98, Change: -4.13, Percent Change: -2.97

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10